Literature DB >> 903173

Intestinal absorption of botulinum toxins of different molecular sizes in rats.

S Sugii, I Ohishi, G Sakaguchi.   

Abstract

During a period of 10 to 12 h after injection of type B 16S (L) toxin into the ligated duodenum of rats, 0.01 to 0.1% of the total toxicity administered was found in the lymph drawn by cannulation of the thoracic duct. The recovery was 50 to 100 times higher than that of the rat given type B 12S (M) or 7S (S) toxin. During the same period, 0.6 to 1.5% of the specific antigens were recovered, regardless of the molecular size of the toxin that had been administered. In lymph of the B-L or B-M toxin recipient, the toxic and nontoxic components were detected in comparable quantities, indicating that the undissociated progenitor toxin molecule is absorbed through the intestinal wall. Although the toxic component had lost its toxic activity, the two components of B-M toxin appearing in lymph reassembled to reconstruct the 12S molecule, whereas those of B-L toxin did not, although the toxic component was still active. Type B-L, B-M, and B-S toxins showed similar stabilities to in vitro exposure to rat lymph (pH 8.2), but B-L toxin showed a considerably higher stability to intestinal juice (pH 7.0) than did B-M toxin. Thus, the toxicity of lymph of rats administered botulinum toxin intraduodenally depends not upon the rate of absorption, but largely upon the stability in the intestine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 903173      PMCID: PMC421150          DOI: 10.1128/iai.17.3.491-496.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  The most poisonous poison.

Authors:  C LAMANNA
Journal:  Science       Date:  1959-09-25       Impact factor: 47.728

2.  Studies on immunity to toxins of Clostridium botulinum. I. A simplified procedure for isolation of type A toxin.

Authors:  J T DUFF; G G WRIGHT; J KLERER; D E MOORE; R H BIBLER
Journal:  J Bacteriol       Date:  1957-01       Impact factor: 3.490

3.  The absorption of Clostridium botulinum type A toxin from the alimentary canal.

Authors:  A J MAY; B C WHALER
Journal:  Br J Exp Pathol       Date:  1958-06

4.  Studies on the oral toxicity of Clostridium botulinum toxin, type A.

Authors:  I W COLEMAN
Journal:  Can J Biochem Physiol       Date:  1954-01

5.  Route of absorption of colostrum globulin in the newborn animal.

Authors:  R S COMLINE; H E ROBERTS; D A TITCHEN
Journal:  Nature       Date:  1951-04-07       Impact factor: 49.962

6.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

7.  Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

8.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  The ingestion of proteins and colloidal materials by columnar absorptive cells of the small intestine in suckling rats and mice.

Authors:  S L CLARK
Journal:  J Biophys Biochem Cytol       Date:  1959-01-25

10.  On the size of the toxic particle passing the intestinal barrier in botulism.

Authors:  R J HECKLY; G J HILDEBRAND; C LAMANNA
Journal:  J Exp Med       Date:  1960-06-01       Impact factor: 14.307

View more
  17 in total

1.  Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Authors:  A B Maksymowych; M Reinhard; C J Malizio; M C Goodnough; E A Johnson; L L Simpson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species.

Authors:  F Chen; G M Kuziemko; R C Stevens
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms.

Authors:  F Chen; G M Kuziemko; P Amersdorfer; C Wong; J D Marks; R C Stevens
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains.

Authors:  Guangyun Lin; William H Tepp; Marite Bradshaw; Chase M Fredrick; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2014-10-31       Impact factor: 4.792

5.  Characterization of botulinum progenitor toxins by mass spectrometry.

Authors:  Harry B Hines; Frank Lebeda; Martha Hale; Ernst E Brueggemann
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

Review 6.  The "Leaky Gut": Tight Junctions but Loose Associations?

Authors:  Daniel Hollander; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2020-05       Impact factor: 3.199

Review 7.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

Review 8.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

9.  Oral toxicities of Clostridium botulinum type A and B toxins from different strains.

Authors:  I Ohishi
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores.

Authors:  H Sugiyama; D C Mills
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.